awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35231826-312F69D6-E1C8-422E-AC77-3F7BD259E3EC
Q35231826-312F69D6-E1C8-422E-AC77-3F7BD259E3EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35231826-312F69D6-E1C8-422E-AC77-3F7BD259E3EC
Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
P2860
Q35231826-312F69D6-E1C8-422E-AC77-3F7BD259E3EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35231826-312F69D6-E1C8-422E-AC77-3F7BD259E3EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
966528fce6da87a67c64b3b0add2cb5df3955829
P2860
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma